Neurogene Inc (NGNE)

05:43 AM

Neurogene presents HLH treatment strategy at ASGCT meeting By Investing.com - Investing.com Nigeria

05:43 AM

01:33 AM

Brokerages Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $46.20 - Defense World

01:33 AM

May 16, 2025

Neurogene Shares Drop After Downgrade From Baird - marketscreener.com

May 16, 2025

May 16, 2025

Neurogene stock downgraded at Baird (NGNE:NASDAQ) - Seeking Alpha

May 16, 2025

May 16, 2025

Neurogene (NGNE) Downgraded to Neutral with Lowered Price Target | NGNE Stock News - GuruFocus

May 16, 2025

May 16, 2025

Neurogene (NGNE) Presents New Protocol for Tackling Gene Therapy - GuruFocus

May 16, 2025

May 16, 2025

Neurogene presents HLH treatment strategy at ASGCT meeting - Investing.com Australia

May 16, 2025

May 16, 2025

Neurogene Announces Evidence-Based Monitoring And Treatment Intended To Reverse Rare Hyperinflammatory Syndrome Associated With High-Dose Aav - marketscreener.com

May 16, 2025

May 16, 2025

Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV - Eagle-Tribune

May 16, 2025

May 16, 2025

Neurogene (NGNE) Downgraded by Baird Amid Regulatory Concerns | - GuruFocus

May 16, 2025

May 16, 2025

Baird cuts Neurogene stock rating, lowers price target to $24 By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Q2 Earnings Estimate for Neurogene Issued By HC Wainwright - Defense World

May 16, 2025

May 15, 2025

Rett Syndrome treatment Market Is Booming Worldwide 2025-2032 | - openPR.com

May 15, 2025

May 15, 2025

HC Wainwright Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock Price - Defense World

May 15, 2025

May 13, 2025

Neurogene (NGNE) Analyst Rating Update: Target Price Adjusted | - GuruFocus

May 13, 2025

May 13, 2025

Neurogene (NGNE) Target Price Reduced, Buy Rating Maintained | N - GuruFocus

May 13, 2025

May 11, 2025

Wells Fargo & Company MN Purchases 1,397 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 11, 2025

May 10, 2025

Barclays PLC Has $401,000 Position in Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 10, 2025

May 10, 2025

Neurogene: Q1 Earnings Snapshot - San Francisco Chronicle

May 10, 2025

May 09, 2025

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 8, 2025 - BioSpace

May 09, 2025

May 09, 2025

Neurogene Reports Q1 2025 Financial Results and Advances Rett Syndrome Gene Therapy - TipRanks

May 09, 2025

May 09, 2025

NEUROGENE Earnings Results: $NGNE Reports Quarterly Earnings - Nasdaq

May 09, 2025

May 09, 2025

Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates - Business Wire

May 09, 2025

May 07, 2025

Daily Market Movement: Neurogene Inc (NGNE) Sees a -13.63 Decrease, Closing at 13.05 - DWinneX

May 07, 2025

May 07, 2025

10,475 Shares in Neurogene Inc. (NASDAQ:NGNE) Bought by Mariner LLC - Defense World

May 07, 2025

May 06, 2025

Neurogene Inc expected to post a loss of $1.06 a shareEarnings Preview - TradingView

May 06, 2025

May 02, 2025

Neurogene (NGNE) Expected to Announce Earnings on Friday - Defense World

May 02, 2025

Apr 28, 2025

Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting - BioSpace

Apr 28, 2025

Apr 28, 2025

Neurogene Announces Upcoming Oral Presentation On Monitoring And Treatment To Reverse Rare Complication Of High Dose Gene Therapy - marketscreener.com

Apr 28, 2025

Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

Lost Money on Neurogene Inc. (NGNE)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

Neurogene Inc. (NASDAQ:NGNE) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 26, 2025

Apr 22, 2025

Analysts Set Neurogene Inc. (NASDAQ:NGNE) Price Target at $47.20 - Defense World

Apr 22, 2025

Apr 15, 2025

Wellington Management Group LLP Grows Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - The AM Reporter

Apr 15, 2025

Apr 15, 2025

BMO cuts Neurogene stock target to $16 from $45, keeps Outperform By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Wellington Management Group LLP Increases Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - Defense World

Apr 15, 2025

Apr 15, 2025

JPMorgan Chase & Co. Purchases 476,418 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World

Apr 15, 2025

Apr 15, 2025

Neurogene (NASDAQ:NGNE) Given New $16.00 Price Target at BMO Capital Markets - Defense World

Apr 15, 2025

Apr 14, 2025

Neurogene Inc. Amends Agreement, Issues Warrants By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

Neurogene Inc. Amends Agreement, Issues Warrants - Investing.com

Apr 14, 2025

Apr 14, 2025

Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold - marketscreener.com

Apr 14, 2025

Apr 14, 2025

BMO cuts Neurogene stock target to $16 from $45, keeps Outperform - Investing.com Canada

Apr 14, 2025

Apr 10, 2025

NGNE Stock Sees Decline of Approximately -13.67% in Last Five Days - knoxdaily.com

Apr 10, 2025

Apr 07, 2025

NGNE stock touches 52-week low at $8.35 amid market challenges - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

NGNE stock touches 52-week low at $8.35 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025